Nantahala Capital Management - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 59 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2022$521,721
-62.4%
289,845
-55.8%
0.03%
-62.2%
Q3 2022$1,389,000
-34.2%
655,338
-16.5%
0.09%
-15.1%
Q2 2022$2,111,000
-45.6%
784,798
-12.2%
0.11%
-38.4%
Q1 2022$3,878,000
-27.3%
893,561
-13.2%
0.17%
-8.5%
Q4 2021$5,335,000
-16.8%
1,029,872
-1.4%
0.19%
-6.9%
Q3 2021$6,412,000
-46.7%
1,044,267
-12.3%
0.20%
-40.9%
Q2 2021$12,027,0001,190,8100.34%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders